Key result
Atrial leadless pacing offers a potential therapeutic option for selected patients with cardioinhibitory vasovagal syncope.
Why the study?
In patients with cardioinhibitory vasovagal syncope and recurrent syncope despite conservative therapy or cardioneuroablation, the role of atrial leadless pacing remains poorly established.
Atrial leadless pacing may serve as a therapeutic alternative for carefully selected patients with refractory cardioinhibitory vasovagal syncope despite conservative therapy or cardioneuroablation.
Cardioinhibitory vasovagal syncope (VVS) may be associated with prolonged sinus pauses and recurrent syncope despite conservative therapy or cardioneuroablation (CNA). Although permanent pacing may be considered in selected patients, the role of leadless pacing, particularly atrial leadless pacing, remains poorly established; however, it may represent a potential therapeutic option in carefully selected patients.
No takes yet. Share an insight, caveat, or question.
Pérez et al. (2026) studied Cardioinhibitory vasovagal syncope (VVS). Atrial leadless pacing was evaluated. Atrial leadless pacing represents a potential therapeutic option in carefully selected patients with cardioinhibitory vasovagal syncope and recurrent syncope.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: